Biogen
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,465,800 | $2,353,000 | $2,200,300 | $2,386,300 |
Gross Profit | 1,827,100 | 1,648,200 | 1,510,500 | 1,768,000 |
EBITDA | 693,600 | 918,800 | 681,600 | 601,200 |
EBIT | 510,800 | 760,000 | 534,000 | 461,100 |
Net Income | 388,500 | 583,600 | 393,400 | 249,700 |
Net Change In Cash | 2,465,800 | 2,353,000 | 2,200,300 | 2,386,300 |
Free Cash Flow | 805,600 | 583,200 | 432,300 | -52,700 |
Cash | 1,699,200 | 1,908,900 | 1,074,400 | 1,049,900 |
Basic Shares | 145,900 | 145,900 | 145,900 | 145,700 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $9,835,600 | $10,173,400 | $10,981,700 | $13,444,600 |
Gross Profit | 7,302,200 | 7,895,100 | 8,872,000 | 11,639,400 |
EBITDA | 2,377,000 | 4,357,100 | 2,486,100 | 5,730,300 |
EBIT | 1,882,200 | 3,838,400 | 1,998,800 | 5,273,300 |
Net Income | 1,161,100 | 3,046,900 | 1,556,100 | 4,000,600 |
Net Change In Cash | 9,835,600 | 10,173,400 | 10,981,700 | 13,444,600 |
Cost of Revenue | 1,213,600 | 990,000 | -1,651,500 | |
Free Cash Flow | 1,235,800 | 1,141,100 | 3,345,000 | 3,678,000 |
Cash | 1,049,900 | 3,419,300 | 2,261,400 | 1,331,200 |
Basic Shares | 145,600 | 146,000 | 149,600 | 161,300 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $4.08 |
2024-06-30 | $5.28 |
2024-03-31 | $3.67 |
2023-12-31 | $3.30 |
